Jacobs Levy Equity Management
ARRY

Jacobs Levy Equity Management’s Array Biopharma Inc ARRY Stock Holding History

Jacobs Levy Equity Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-82,909
Closed -$1.26M – 1115
2018
Q3 		$1.26M Buy
82,909
+15,349
+23% +$235K 0.02% 613
2018
Q2 		$1.13M Sell
67,560
-20,200
-23% -$321K 0.02% 635
2018
Q1 		$1.43M Buy
87,760
+37,900
+76% +$607K 0.02% 553
2017
Q4 		$638K Buy
49,860
+27,400
+122% +$312K 0.01% 710
2017
Q3 		$276K Buy
+22,460
New +$209K 0.01% 804
2015
Q2 		– Sell
-27,500
Closed -$203K – 889
2015
Q1 		$203K Buy
+27,500
New +$196K ﹤0.01% 701
2014
Q3 		– Sell
-75,700
Closed -$345K – 948
2014
Q2 		$345K Buy
+75,700
New +$313K 0.01% 691
2013
Q3 		– Sell
-146,199
Closed -$664K – 1056
2013
Q2 		$664K Buy
+146,199
New +$786K 0.01% 664

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return